Novel Coronavirus Pneumonia (COVID-19)
Conditions
Interventions
control group:placebo
Sponsors
Beijing University of Chinese Medicine Third Affiliated Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: (1) Convalescent patients with novel coronavious pneumonia,and the patient is aged 18-75 years old; (2) The TCM syndrome type conforms to deficiency of 'qi' and 'yin' and not exhausted of 'Yu Xie'; (3) Voluntary test, or the immediate family or the client's approved client agrees to the test, and voluntarily signs the informed consent; (4) Provide detailed contact information, no short-term willingness to move and be willing to cooperate with followers.
Exclusion criteria
Exclusion criteria: (1) Patients with fasting water due to gastrointestinal bleeding, intestinal obstruction, etc; (2) Patients with pre-existing severe brain, heart, liver, kidney and hematopoietic system diseases; (3) Patients who are known to be allergic to the ingredients of the intervention drug; (4) Patients who are unable to cooperate with follow-up.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| TCM syndrome curative effect; | — |
Secondary
| Measure | Time frame |
|---|---|
| Quality of Life;6MWD;Lung function;Chest CT examination;Reversion rate of viral nucleic acid; | — |
Countries
China
Contacts
Public ContactHongsheng Cui
Beijing University of Chinese Medicine, Third Affiliated Hospital
Outcome results
None listed